Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2025-12-24 @ 11:51 AM
NCT ID:
NCT04003961
Eligibility Criteria:
Inclusion Criteria:
* Patients between 18-75 years of age with the diagnosis of lung cancer (stage 3 and 4 non-small cell lung cancer or limited / extensive small cell lung cancer) and who sign the informed consent to participate in the study
Exclusion Criteria:
* Patients older than 75 years old amd younger than 18 years old
* Sedatives / anxiolytic drug users
* Neurological or psychiatric disorders
* Those who have contradictions for standard chemoradiotherapy (ECOG performance status 3-4)
* Stage 1 or stage 2 non-small cell lung cancer patients who may be referred to thoracic surgery
* Patients with brain metastasis
* People who have a shift work
* Vena cava superior syndrome
* Alcohol dependence
* Malignant airway stenosis
* Congestive heart failure (EF \<50%)
* Patients with chronic renal failure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04003961
Study Brief:
Protocol Section:
NCT04003961